Search results for: 'more'

In recent years, there has been a remarkable surge of interest and investment in women's health and wellness, marking a profound shift toward prioritizing women’s health and empowerment worldwide. As women take center stage in various aspects of society, including leadership roles and decision-making processes, there is increasing recognition of th...

A major challenge in drug discovery is the limited number of gene targets that can be targeted for the development of a drug molecule. Only close to 400 genes are proven targets for US FDA-approved drugs. 80% of human genes are unexplored as targets, and some are considered undruggable. The identification and the selection of novel drug targets (p...

24 Jun 2019  |  North America  |  Market Research

US Clinical Decision Support Systems Market, Forecast to 2024

A Growing Market with an Opportunity to be More than an Adjunct to the EHR

Infographics

×

Clinical Decision Support (CDS) systems are poised to become the user interface of choice for clinical interaction with health IT, ultimately supplanting the EHR system as the primary health IT point of interface for clinicians. This is due the fact that CDS began as a way to deliver medical content and patient information to the caregiver. Unlike ...

01 Mar 2024  |  North America  |  Market Research

Global Orphan Drug Growth Opportunities

Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions

Infographics

×

In this study, Frost & Sullivan s Transformational Health team provides critical insights into the global orphan drug (OD) industry and highlights growth opportunities, revenue, regulatory changes, and technology trends influencing growth. Approximately 5% of rare diseases (RDs) have received US FDA approval for a drug, while up to 15% of RDs have ...

13 Sep 2016  |  North America  |  Market Research

US Next-generation Sequencing Services Market

$1,000 Genome Pricing and Throughput to Drive More and Larger Sequencing Projects

Infographics

×

The next-generation sequencing (NGS) services market includes all sequencing services conducted with next-generation or third-generation platforms that use newer technology than traditional capillary electrophoresis (CE) sequencing. Services include project scoping, NGS sample preparation tasks (i.e., library prep and target enrichment), and NGS-ba...

03 Oct 2022  |  Global  |  Market Research

Global Prenatal Genetic Testing—Forecast to 2026

Innovation Culture in Screening Drives Prenatal Genetic Testing Growth and Makes it Accessible to More Patients

Infographics

×

New technological advances in prenatal genetic testing include the enhancement of the next-generation sequencing (NGS) technology, chromosomal microarray analysis (CMA) tool, and PCR TaqMan. These improve precision and specificity in genome profiling, augment the efficiency and reliability of testing, and streamline workflow. The study will help...

23 Dec 2020  |  North America  |  Market Research

Growth Opportunity Analysis of the North American Clinical Documentation Improvement (CDI) Market

Internal Challenges, Disruptive Technologies, and Competitive Intensity are Driving CDI to become a More Value-based Process

Infographics

×

This Frost & Sullivan research service presents a comprehensive overview of the North American clinical documentation improvement (CDI) market. CDI is a mid-process in the broader revenue cycle management (RCM) ecosystem. This study analyzes key product segments, major end users, and top vendors across the United States and Canada. Revenue is fo...

The neuroimaging industry is dynamic, constantly looking for novel approaches to identify and cure complex neurological disorders. Emerging MRI and CT technologies have helped address the challenges in neuroimaging, such as limited spatiotemporal resolution, cost and accessibility, and patient safety. This study examines emerging technologies, ...

27 Nov 2017  |  North America  |  Market Research

Growth Opportunities in the Global Digital Pathology Market, Forecast to 2021

New Business Models and More FDA Approvals of WSI Scanners for Primary Diagnostics are Set to Boost Growth of Digital Pathology

Infographics

×

Key Issues Addressed

Shortage of pathologists and the rise in new cancer cases are the key drivers for the adoption of digital pathology solutions globally. Digital pathology enhances the productivity of pathologists by 10% to 15%, thereby improving the overall efficiency of healthcare providers. Digital pathology solutions find the best fit in oncology care. Accordin...